Trump Signs Order to Accelerate Access to Psychedelic Drug Treatments WASHINGTON, April 18 (Reuters) - U.S. President Donald Trump signed an executive order on Saturday ⁠intended ⁠to speed up access ...

President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies ...

The FDA announced on April 24, 2026, that it has granted a new class of accelerated review vouchers to three psychedelic drug programs, a move that could compress the agency’s standard 10- to 12-month ...

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The ...

The executive order notes that more than 14 million American adults now suffer from serious mental illness, a large rise from a decade ago. Trump’s executive order instructs the Food and Drug ...

The FDA announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. It's a significant step toward supporting psychedelic-based medicines ...

President Donald Trump aims to fast-track research into psychedelic therapy for conditions like post traumatic stress disorder and depression in a break from his first administration policy. Advocates ...

President Donald Trump’s executive order aimed at fast-tracking research into the medical use of psychedelics will almost certainly open the door to experimenting with psychedelic therapies for ...

May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate psychedelic drug ⁠development ⁠has raised hopes among companies developing the drugs that it could ⁠help attract more ...